vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and CONSUMER PORTFOLIO SERVICES, INC. (CPSS). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $109.4M, roughly 1.1× CONSUMER PORTFOLIO SERVICES, INC.). CONSUMER PORTFOLIO SERVICES, INC. runs the higher net margin — 4.6% vs 4.2%, a 0.3% gap on every dollar of revenue. On growth, CONSUMER PORTFOLIO SERVICES, INC. posted the faster year-over-year revenue change (3.9% vs -1.4%). CONSUMER PORTFOLIO SERVICES, INC. produced more free cash flow last quarter ($288.3M vs $517.0K). Over the past eight quarters, CONSUMER PORTFOLIO SERVICES, INC.'s revenue compounded faster (9.2% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Consumer Portfolio Services, Inc. is a U.S. specialty finance firm providing indirect auto loan financing and servicing for consumers with limited or subprime credit. It partners with franchised and independent car dealerships nationwide to originate installment contracts for new and used vehicle purchases.

CLB vs CPSS — Head-to-Head

Bigger by revenue
CLB
CLB
1.1× larger
CLB
$121.8M
$109.4M
CPSS
Growing faster (revenue YoY)
CPSS
CPSS
+5.3% gap
CPSS
3.9%
-1.4%
CLB
Higher net margin
CPSS
CPSS
0.3% more per $
CPSS
4.6%
4.2%
CLB
More free cash flow
CPSS
CPSS
$287.8M more FCF
CPSS
$288.3M
$517.0K
CLB
Faster 2-yr revenue CAGR
CPSS
CPSS
Annualised
CPSS
9.2%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
CPSS
CPSS
Revenue
$121.8M
$109.4M
Net Profit
$5.1M
$5.0M
Gross Margin
Operating Margin
1.5%
6.6%
Net Margin
4.2%
4.6%
Revenue YoY
-1.4%
3.9%
Net Profit YoY
-3.2%
EPS (diluted)
$0.11
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
CPSS
CPSS
Q1 26
$121.8M
Q4 25
$138.3M
$109.4M
Q3 25
$134.5M
$108.4M
Q2 25
$130.2M
$109.8M
Q1 25
$123.6M
$106.9M
Q4 24
$129.2M
$105.3M
Q3 24
$134.4M
$100.6M
Q2 24
$130.6M
$95.9M
Net Profit
CLB
CLB
CPSS
CPSS
Q1 26
$5.1M
Q4 25
$4.9M
$5.0M
Q3 25
$14.2M
$4.9M
Q2 25
$10.6M
$4.8M
Q1 25
$-154.0K
$4.7M
Q4 24
$7.4M
$5.1M
Q3 24
$11.7M
$4.8M
Q2 24
$9.0M
$4.7M
Gross Margin
CLB
CLB
CPSS
CPSS
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
CPSS
CPSS
Q1 26
1.5%
Q4 25
11.5%
6.6%
Q3 25
15.6%
6.5%
Q2 25
11.7%
6.3%
Q1 25
3.6%
6.4%
Q4 24
11.0%
7.0%
Q3 24
14.7%
6.8%
Q2 24
12.3%
7.0%
Net Margin
CLB
CLB
CPSS
CPSS
Q1 26
4.2%
Q4 25
3.6%
4.6%
Q3 25
10.6%
4.5%
Q2 25
8.2%
4.4%
Q1 25
-0.1%
4.4%
Q4 24
5.7%
4.9%
Q3 24
8.7%
4.8%
Q2 24
6.9%
4.9%
EPS (diluted)
CLB
CLB
CPSS
CPSS
Q1 26
$0.11
Q4 25
$0.11
$0.21
Q3 25
$0.30
$0.20
Q2 25
$0.22
$0.20
Q1 25
$0.00
$0.19
Q4 24
$0.15
$0.21
Q3 24
$0.25
$0.20
Q2 24
$0.19
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
CPSS
CPSS
Cash + ST InvestmentsLiquidity on hand
$22.8M
$6.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$309.5M
Total Assets
$587.7M
$3.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
CPSS
CPSS
Q1 26
$22.8M
Q4 25
$22.7M
$6.3M
Q3 25
$25.6M
$9.4M
Q2 25
$31.2M
$15.8M
Q1 25
$22.1M
$29.8M
Q4 24
$19.2M
$11.7M
Q3 24
$21.5M
$8.1M
Q2 24
$17.7M
$9.8M
Total Debt
CLB
CLB
CPSS
CPSS
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
CPSS
CPSS
Q1 26
$275.1M
Q4 25
$266.0M
$309.5M
Q3 25
$271.3M
$307.6M
Q2 25
$261.3M
$303.1M
Q1 25
$253.4M
$298.4M
Q4 24
$246.6M
$292.8M
Q3 24
$250.7M
$285.1M
Q2 24
$240.3M
$280.3M
Total Assets
CLB
CLB
CPSS
CPSS
Q1 26
$587.7M
Q4 25
$584.0M
$3.9B
Q3 25
$591.4M
$3.8B
Q2 25
$602.1M
$3.8B
Q1 25
$591.5M
$3.7B
Q4 24
$585.1M
$3.5B
Q3 24
$600.5M
$3.5B
Q2 24
$597.8M
$3.3B
Debt / Equity
CLB
CLB
CPSS
CPSS
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
CPSS
CPSS
Operating Cash FlowLast quarter
$4.0M
$289.0M
Free Cash FlowOCF − Capex
$517.0K
$288.3M
FCF MarginFCF / Revenue
0.4%
263.5%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
0.77×
58.02×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$500.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
CPSS
CPSS
Q1 26
$4.0M
Q4 25
$7.9M
$289.0M
Q3 25
$8.5M
$84.9M
Q2 25
$13.9M
$54.5M
Q1 25
$6.7M
$73.9M
Q4 24
$20.6M
$233.8M
Q3 24
$13.1M
$69.8M
Q2 24
$17.1M
$43.3M
Free Cash Flow
CLB
CLB
CPSS
CPSS
Q1 26
$517.0K
Q4 25
$5.0M
$288.3M
Q3 25
$6.5M
$84.9M
Q2 25
$10.4M
$54.3M
Q1 25
$3.9M
$73.4M
Q4 24
$17.4M
$233.3M
Q3 24
$10.4M
$69.7M
Q2 24
$14.3M
$43.1M
FCF Margin
CLB
CLB
CPSS
CPSS
Q1 26
0.4%
Q4 25
3.6%
263.5%
Q3 25
4.8%
78.3%
Q2 25
8.0%
49.5%
Q1 25
3.1%
68.7%
Q4 24
13.4%
221.6%
Q3 24
7.7%
69.3%
Q2 24
10.9%
45.0%
Capex Intensity
CLB
CLB
CPSS
CPSS
Q1 26
Q4 25
2.1%
0.6%
Q3 25
1.5%
0.0%
Q2 25
2.7%
0.1%
Q1 25
2.3%
0.4%
Q4 24
2.5%
0.4%
Q3 24
2.0%
0.1%
Q2 24
2.2%
0.2%
Cash Conversion
CLB
CLB
CPSS
CPSS
Q1 26
0.77×
Q4 25
1.61×
58.02×
Q3 25
0.60×
17.50×
Q2 25
1.31×
11.35×
Q1 25
15.74×
Q4 24
2.78×
45.43×
Q3 24
1.12×
14.55×
Q2 24
1.90×
9.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons